NICOLE TIEN: Open Payments
NPI 1861119356 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 58 payments from 18 companies in 2025. Trend: 2023 $688 · 2024 $1,387 · 2025 $1,674
Food & beverage: $1,503Education: $171
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $275 |
| GENZYME CORPORATION | 7 | $265 |
| LEO Pharma Inc. | 11 | $259 |
| Incyte Corporation | 8 | $179 |
| Janssen Biotech, Inc. | 3 | $124 |
| ABBVIE INC. | 5 | $109 |
| Amgen Inc. | 3 | $74 |
| Medimetriks Pharmaceuticals, Inc. | 3 | $70 |
| Arcutis Biotherapeutics, Inc. | 3 | $62 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $51 |
Products named: DUPIXENT, ANZUPGO, OPZELURA, TREMFYA, Otezla, Genadur, LIBTAYO, Zoryve.
Industry payments across CA — which companies pay providers there.
